Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Tools & Technology » Informatics » SEngine Precision Medicine Licenses Hutch Cancer Drug Screening Assay

SEngine Precision Medicine Licenses Hutch Cancer Drug Screening Assay

Jul 06, 2017
|
staff reporter

NEW YORK (GenomeWeb) – SEngine Precision Medicine has inked an exclusive licensing agreement with the Fred Hutchinson Cancer Research Center to market a diagnostic test designed to aid in the personalization of cancer treatments.

The assay, called PARIS, combines high-throughput drug screening of live, patient-derived tumor cells with DNA sequencing and data analysis to match individuals with optimal drug therapies.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Working Out the Effect

The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.

Increased Genetic Privacy in Florida

Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.

Attention-Grabbing in Two Ways

A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.

Nature Papers Describe CRISPR Plant Editing Methods, DNA-PAINT Improvements, More

In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.

Jul
09
Featured Webinar

Our Magic DRAGEN: A Sequencing Lab Case Study on Accelerated Bioinformatics

Sponsored by
Illumina

In this webinar, Dr. Charlie Johnson, founder of the Texas A&M AgriLife Genomics and Bioinformatics Service, will share how his team is utilizing Illumina’s DRAGEN informatics platform in its high-throughput agrigenomics research program. 

Jul
22
Featured Webinar

Advances in Genetic Testing for IVF Research: PGT-A, PGT-M, and Carrier Screening

Sponsored by
Thermo Fisher Scientific

Luis A. Alcaraz, cofounder of Bioarray and Journey Genomics, accredited diagnostic and research labs based in Alicante, Spain, will review how his teams use advanced genomic techniques for carrier screening research as well as for preimplantation genetic testing (PGT) in embryos for both aneuploidies (PGT-A) and monogenic disorders (PGT-M).

Jul
29
Featured Webinar

Life Science Marketing Workshop: Creating a Go-To-Market Strategy in a Rapidly Evolving Sector

Sponsored by
Illumina

“If we build it, they will come” is a familiar refrain that echoes in life science entrepreneurial circles. Too frequently startups believe that if a technology is built it will sell.

Sep
17
Featured Webinar

Clinical Diagnosis of Developmental Disorders with Chromosomal Microarrays

Sponsored by
Thermo Fisher Scientific

The prevalence of developmental disability among US children aged 3 to 17 years increased between 2009 and 2017, with as many as 1 in 6 children in the US reported to have a developmental disability diagnosis.

What's Popular?

In Informatics

  1. NIH Allocates $75M to Create eMERGE Risk Assessment Network

  2. Cancer AI Startup Nucleai Raises $6.5M in Series A

  3. Genomics England, Sano, Zetta Building Platform to Support Rare Disease Patient Participation

    Premium

  4. Argonne, UAE Ministry of Health Install New Nvidia GPUs for COVID-19 Analysis

    Premium

  5. Celsius Therapeutics Teams With Oxford, Cleveland Clinic, LMU on Single-Cell IBD Research

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.